Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow‐on formula manufactured from hydrolysed protein by HIPP‐Werk Georg Hipp OHG (dossier submitted by meyer.science GmbH) [PDF]
The European Commission asked EFSA to deliver an opinion on the nutritional safety and suitability of a specific protein hydrolysate. It is derived from whey protein concentrate and used in infant and follow‐on formula by HIPP‐Werk Georg Hipp OHG.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) +22 more
doaj +2 more sources
Nutritional safety and suitability of a specific protein hydrolysate derived from a whey protein concentrate and used in an infant formula and follow‐on formula manufactured from hydrolysed protein by FrieslandCampina Nederland B.V. [PDF]
The European Commission asked EFSA to deliver an opinion on the nutritional safety and suitability of a specific protein hydrolysate. It is derived from a whey protein concentrate and used in an infant and follow‐on formula manufactured by ...
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) +21 more
doaj +2 more sources
Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow‐on formula manufactured from hydrolysed protein by Danone Trading ELN B.V. [PDF]
The European Commission asked EFSA to deliver an opinion on the nutritional safety and suitability of a specific protein hydrolysate. It is derived from whey protein concentrate and used in an infant and follow‐on formula by Danone Trading ELN B.V, which
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) +22 more
doaj +2 more sources
Nutritional safety and suitability of a specific protein hydrolysate derived from sources of skimmed cow's milk and whey protein concentrates and used in infant and follow‐on formula manufactured from hydrolysed protein by Healthcare Reckitt B.V. [PDF]
The European Commission (EC) requested the European Food Safety Authority to evaluate the nutritional safety and suitability of a specific protein hydrolysate derived from sources of skimmed cow's milk (including non‐fat) and whey protein concentrates ...
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) +18 more
doaj +2 more sources
Nutritional safety and suitability of a specific protein hydrolysate manufactured by Fonterra Co‐operative Group Ltd derived from a whey protein concentrate and used in infant formula and follow‐on formula [PDF]
The European Commission asked EFSA to deliver an opinion on the nutritional safety and suitability for use in infant and follow‐on formula of a specific protein hydrolysate from whey protein concentrate manufactured by Fonterra Co‐operative Group Ltd ...
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) +18 more
doaj +2 more sources
Quality and safety in clinical nutrition [PDF]
Clinical nutrition and food provision in a hospital environment must be regulated by quality management programs that ensure maximum clinical benefit and maximum patient safety. This article gives an overview of quality management in clinical nutrition and hospital feeding.
Mariola, Sirvent Ochando +2 more
openaire +2 more sources
Safety in parenteral nutrition compounding
AbstractParenteral nutrition (PN) compounding is a complex process that requires knowledge and training to ensure the safety and efficacy of this form of nutrition support therapy. Unfortunately, errors and lack of adherence to safe PN compounding recommendations and sterile compounding requirements have resulted in patient injury and death.
Andrew Mays +3 more
openaire +2 more sources
This research aims to establish an HPLC method for the simultaneous determination of konjac glucomannan (KGM) and starch in konjac powder. In this paper, konjac powder was hydrolyzed into glucose and mannose by acid hydrolysis.
WU Bo +5 more
doaj +1 more source
Objective Erucin (ERN), an isothiocyanate, is derived from the vegetable arugula. Although ERN has antitumor and antioxidant activity, the effect of ERN on osteoclast and osteoblast differentiation is not well documented.
Tomohiro Takagi +4 more
doaj +1 more source
Multiple mechanisms are involved in exercise-induced fatigue, including energy depletion, metabolite accumulation, and oxidative stress, etc. The mechanistic findings provide a rationale for a multi-targeted approach to exercise-induced fatigue ...
Hui Chen +6 more
doaj +1 more source

